Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults.

Polgreen LE, Jacobs DR Jr, Nathan BM, Steinberger J, Moran A, Sinaiko AR.

Obesity (Silver Spring). 2012 Nov;20(11):2194-201. doi: 10.1038/oby.2012.108. Epub 2012 Apr 30.

2.

Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study.

Oosterwerff MM, van Schoor NM, Lips P, Eekhoff EM.

Clin Endocrinol (Oxf). 2013 Feb;78(2):242-7. doi: 10.1111/j.1365-2265.2012.04391.x.

PMID:
22435398
3.

Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study.

Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N.

Osteoporos Int. 2012 Feb;23(2):761-70. doi: 10.1007/s00198-011-1600-7. Epub 2011 Mar 25.

PMID:
21437719
4.

Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study.

Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Hankey GJ, Beilby JP, Norman PE.

Osteoporos Int. 2012 Feb;23(2):599-606. doi: 10.1007/s00198-011-1586-1. Epub 2011 Feb 26.

PMID:
21359669
5.

Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey.

Tan A, Gao Y, Yang X, Zhang H, Qin X, Mo L, Peng T, Xia N, Mo Z.

Metabolism. 2011 Aug;60(8):1186-92. doi: 10.1016/j.metabol.2011.01.002. Epub 2011 Feb 24.

PMID:
21353261
6.

Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes.

Kanazawa I, Yamaguchi T, Tada Y, Yamauchi M, Yano S, Sugimoto T.

Bone. 2011 Apr 1;48(4):720-5. doi: 10.1016/j.bone.2010.12.020. Epub 2010 Dec 23.

PMID:
21185419
7.

Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men.

Kim SH, Lee JW, Im JA, Hwang HJ.

Clin Chim Acta. 2010 Dec 14;411(23-24):2054-7. doi: 10.1016/j.cca.2010.08.046. Epub 2010 Sep 7.

PMID:
20831864
8.

Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome.

Saleem U, Mosley TH Jr, Kullo IJ.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1474-8. doi: 10.1161/ATVBAHA.110.204859. Epub 2010 Apr 15.

9.

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.

Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T.

Osteoporos Int. 2011 Jan;22(1):187-94. doi: 10.1007/s00198-010-1184-7. Epub 2010 Feb 18.

PMID:
20165834
10.

Gamma-carboxylation of osteocalcin and insulin resistance in older men and women.

Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL.

Am J Clin Nutr. 2009 Nov;90(5):1230-5. doi: 10.3945/ajcn.2009.28151. Epub 2009 Sep 23.

11.

Association between serum osteocalcin and markers of metabolic phenotype.

Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B.

J Clin Endocrinol Metab. 2009 Mar;94(3):827-32. doi: 10.1210/jc.2008-1422. Epub 2008 Dec 16.

12.

Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men.

Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U, Mellström D.

J Bone Miner Res. 2009 May;24(5):785-91. doi: 10.1359/jbmr.081234. Erratum in: J Bone Miner Res. 2010 Dec;25(12):2527.

13.

The bone-adipose axis in obesity and weight loss.

Gómez-Ambrosi J, Rodríguez A, Catalán V, Frühbeck G.

Obes Surg. 2008 Sep;18(9):1134-43. doi: 10.1007/s11695-008-9548-1. Epub 2008 Jun 19. Review.

PMID:
18563500
14.

Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

Ferron M, Hinoi E, Karsenty G, Ducy P.

Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5266-70. doi: 10.1073/pnas.0711119105. Epub 2008 Mar 24.

15.

Endocrine regulation of energy metabolism by the skeleton.

Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G.

Cell. 2007 Aug 10;130(3):456-69.

16.

Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.

Sierra-Johnson J, Somers VK, Kuniyoshi FH, Garza CA, Isley WL, Gami AS, Lopez-Jimenez F.

Am J Cardiol. 2006 Nov 15;98(10):1369-73. Epub 2006 Sep 29.

PMID:
17134631
17.
18.
19.

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E.

Lancet. 2001 Dec 15;358(9298):2026-33.

PMID:
11755609
20.
Items per page

Supplemental Content

Write to the Help Desk